| 17/07/26 | 12:25:01 | 17 Jul 2026 | | Result of AGM, Warrants & Directorate Change |
| 22/06/26 | 07:00:11 | 22 Jun 2026 | | Conclusion of Evaluation with University of Dundee |
| 22/06/26 | 07:00:09 | 22 Jun 2026 | | Final Results & Notice of AGM |
| 02/06/26 | 07:00:05 | 2 Jun 2026 | | Conclusion of Evaluation with Stingray |
| 01/06/26 | 07:00:12 | 1 Jun 2026 | | ValiRx Exercises Option on Evaluation Asset |
| 27/05/26 | 07:00:06 | 27 May 2026 | | Cytolytix Patent Granted |
| 21/05/26 | 07:00:06 | 21 May 2026 | | Result of Oversubscribed WRAP Retail Offer |
| 18/05/26 | 07:00:10 | 18 May 2026 | | WRAP Retail Offer for up to £150,000 |
| 15/05/26 | 07:00:04 | 15 May 2026 | | Fundraising of up to £1,155,000 |
| 31/03/26 | 10:15:00 | 31 Mar 2026 | | Change of Registered Office |
| 26/03/26 | 07:00:05 | 26 Mar 2026 | | ValiRx Commercial Update Q1 2026 |
| 24/03/26 | 07:00:12 | 24 Mar 2026 | | ValiRx and TwinEdge to present Digital Twin data |
| 04/03/26 | 07:00:09 | 4 Mar 2026 | | Director/PDMR Shareholding |
| 02/03/26 | 07:00:15 | 2 Mar 2026 | | ValiRx forms ValiRx Animal Health Ltd subsidiary |
| 19/01/26 | 07:00:05 | 19 Jan 2026 | | Exercise of Warrants |
| 09/01/26 | 15:45:00 | 9 Jan 2026 | | Replacement: Evaluation and Transfer Agreement |
| 09/01/26 | 07:00:05 | 9 Jan 2026 | | New Evaluation and Material Transfer Agreement |
| 08/01/26 | 13:00:00 | 8 Jan 2026 | | Holding(s) in Company |
| 05/12/25 | 10:56:01 | 5 Dec 2025 | | Holding(s) in Company |
| 24/11/25 | 15:54:14 | 24 Nov 2025 | | Holding(s) in Company |
| 24/11/25 | 09:30:01 | 24 Nov 2025 | | Holding(s) in Company |
| 20/11/25 | 12:11:58 | 20 Nov 2025 | | Result of GM & Issue of Equity |
| 13/11/25 | 14:16:00 | 13 Nov 2025 | | Holding(s) in Company |
| 10/11/25 | 07:00:10 | 10 Nov 2025 | | Holding(s) in Company |
| 04/11/25 | 17:15:44 | 4 Nov 2025 | | Posting of Circular and Notice of General Meeting |
| 04/11/25 | 07:00:11 | 4 Nov 2025 | | Result of WRAP Retail Offer |
| 30/10/25 | 07:21:14 | 30 Oct 2025 | | WRAP Retail Offer for up to £300,000 |
| 30/10/25 | 07:17:30 | 30 Oct 2025 | | Fundraising of up to £1,050,000 |
| 14/10/25 | 07:00:08 | 14 Oct 2025 | | Inaphaea Commercial update |
| 29/09/25 | 07:00:12 | 29 Sept 2025 | | Half-year Report |
| 18/09/25 | 07:00:09 | 18 Sept 2025 | | Inaphaea Commercial Update |
| 01/09/25 | 07:00:10 | 1 Sept 2025 | | Cytolytix Commercial update |
| 26/08/25 | 07:00:12 | 26 Aug 2025 | | Commercial update |
| 07/08/25 | 10:51:16 | 7 Aug 2025 | | ValiRx Awarded Grant from Open University |
| 05/08/25 | 09:53:20 | 5 Aug 2025 | | Update on Evaluation Agreement with Stingray Bio |
| 04/08/25 | 07:00:13 | 4 Aug 2025 | | Licensing Agreement with Dominion Biotech Ltd |
| 29/07/25 | 07:00:10 | 29 Jul 2025 | | Collaboration Agreement with Voxcell BioInnovation |
| 30/06/25 | 15:48:43 | 30 Jun 2025 | | Result of AGM |
| 20/06/25 | 07:00:02 | 20 Jun 2025 | | Ambrose Exercise Option on VAL401 |
| 09/06/25 | 10:57:09 | 9 Jun 2025 | | ValiRx Investor Webinar |
| 06/06/25 | 10:54:37 | 6 Jun 2025 | | Holding(s) in Company |
| 06/06/25 | 07:00:11 | 6 Jun 2025 | | Final Results & Notice of AGM |
| 03/06/25 | 07:00:09 | 3 Jun 2025 | | New Evaluation and Material Transfer Agreement |
| 20/05/25 | 13:25:16 | 20 May 2025 | | Holding(s) in Company |
| 12/05/25 | 07:00:08 | 12 May 2025 | | Inaphaea Deal Extension With Dominion |
| 30/04/25 | 07:00:09 | 30 Apr 2025 | | Commercial Update |
| 03/04/25 | 07:00:09 | 3 Apr 2025 | | Termination of Letter of Intent with TheoremRx |
| 27/03/25 | 07:00:15 | 27 Mar 2025 | | Directorate Changes and new Advisory Board |
| 21/03/25 | 11:07:30 | 21 Mar 2025 | | Director Disclosure Update |
| 24/02/25 | 07:00:03 | 24 Feb 2025 | | Conclusion of Evaluation Project |
